Evidence map›Paper›PMID 30994095›Full record

ArticleThe American journal of tropical medicine and hygiene2019

A Direct from Blood/Plasma Reverse Transcription-Polymerase Chain Reaction for Dengue Virus Detection in Point-of-Care Settings.

Ninad Mehta, Bastien Perrais, Kimberly Martin, Anil Kumar, Tom C Hobman, Mary Noreen Cabalfin-Chua, Manuel Emerson Donaldo, Maria Salome Siose Painaga, James Yared Gaite, Vanessa Tran and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Ninad MehtaSchool of Public Health, University of Alberta, Edmonton, Canada.
Bastien PerraisSchool of Public Health, University of Alberta, Edmonton, Canada.
Kimberly MartinSchool of Public Health, University of Alberta, Edmonton, Canada.
Anil KumarDepartment of Cell Biology, University of Alberta, Edmonton, Canada.
Tom C HobmanDepartment of Medical Microbiology and Immunology, University of Alberta, Edmonton, Canada.
Mary Noreen Cabalfin-ChuaSection of Pediatric Infectious Diseases, Department of Pediatrics, Chong Hua Hospital, Cebu, Philippines.
Manuel Emerson DonaldoCebu Institute of Medicine, Cebu, Philippines.
Maria Salome Siose PainagaLebumfacil-Santa Ana Medical Center, Cebu, Philippines.
James Yared GaiteLebumfacil-Santa Ana Medical Center, Cebu, Philippines.
Vanessa TranTropical Disease Unit, The University Health Network-Toronto General Hospital, University of Toronto, Toronto, Canada.
Kevin C KainTropical Disease Unit, The University Health Network-Toronto General Hospital, University of Toronto, Toronto, Canada.
Michael T HawkesSchool of Public Health, University of Alberta, Edmonton, Canada.
Stephanie K YanowDepartment of Medical Microbiology and Immunology, University of Alberta, Edmonton, Canada.
University of Alberta · CAUniversity of Toronto · CAChang Hua Hospital · TW

Funding

CIHR FDN-148439
6 · The paper itself

Abstract

Infection with dengue virus (DENV) is widespread across tropical regions and can result in severe disease. Early diagnosis is important both for patient management and to differentiate infections that present with similar symptoms, such as malaria, chikungunya, and Zika. Rapid diagnostic tests that are used presently for point-of-care detection of DENV antigens lack the sensitivity of molecular diagnostics that detect viral RNA. However, no molecular diagnostic test for DENV is available for use in field settings. In this study, we developed and validated a reverse transcription-polymerase chain reaction (RT-PCR) for the detection of DENV adapted for use in field settings. Reverse transcription-polymerase chain reaction was performed directly from plasma samples without RNA extraction. The assay detected all four serotypes of DENV spiked into blood or plasma. Our RT-PCR does not cross-react with pathogens that cause symptoms that overlap with dengue infection. The test performed equally well in a conventional laboratory qPCR instrument and a small, low-cost portable instrument that can be used in a field setting. The lower limit of detection for the assay was 1 × 10

Indexed as

Point-of-Care TestingAlphavirusAnimalsChlorocebus aethiopsDengueDengue VirusHumansImmunoassayPlasmodium falciparumPlasmodium vivaxPolymerase Chain ReactionRNA, ViralSensitivity and SpecificitySerologic TestsSpecies SpecificityVero CellsRNA, Viral

Identifiers

PMID30994095
PMCPMC6553918
OpenAlexW2938389305

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.